Cue Health (HLTHQ) Hisse Fiyat
Cue Health Fiyat
Cue Health, son 4 yılda gelirini yıllık %76,4 artırarak 64,22 M USD seviyesine taşıdı. Cue Health için net marj, %-581,5 ile birkaç yıl önceki %-311,0 seviyesine göre geriledi.
Cue Health hisse senedi fiyatı
Bu verilere Eulerpool API üzerinden ulaşın
Ayda 100.000 ücretsiz istek · kredi kartı yok
Cue Health iş modeli ve hisse analizi
Cue Health hakkında sık sorulan sorular
The business model of Cue Health Inc is centered around the development and commercialization of diagnostic products for professional and consumer use. Cue Health Inc focuses on molecular diagnostics, leveraging biotechnology, software, and engineering to provide rapid and accurate results. By combining portable and easy-to-use platforms with a wide range of applications, Cue Health Inc aims to empower individuals and healthcare professionals with point-of-care testing solutions. With a focus on user-friendly devices and actionable information, Cue Health Inc strives to improve healthcare outcomes and enhance access to timely and accurate diagnostics.
Cue Health Inc is primarily active in the healthcare industry.
The main competitors of Cue Health Inc in the market include reputable companies such as Abbott Laboratories, Becton, Dickinson and Company (BD), and Roche Diagnostics.
Cue Health Inc is a renowned company specializing in healthcare technology solutions. Established in [year], Cue Health Inc has been at the forefront of developing innovative products for diagnostics and disease monitoring. The company's cutting-edge platform combines advanced molecular diagnostics with user-friendly devices, empowering individuals to take control of their health. With a strong emphasis on accuracy, convenience, and accessibility, Cue Health Inc has built a reputation for delivering reliable and timely results. This commitment to innovation has earned the company widespread recognition and numerous accolades in the healthcare industry. Cue Health Inc continues to revolutionize the way healthcare is delivered, providing individuals and healthcare professionals with valuable tools to make informed decisions and improve overall well-being.
Cue Health Inc has achieved several significant milestones. Notably, the company received Emergency Use Authorization from the U.S. FDA for its rapid, portable COVID-19 test. Cue Health Inc also secured a partnership with the U.S. Department of Health and Human Services to produce and distribute COVID-19 tests. Moreover, the company successfully completed a $100 million funding round, allowing for further expansion and development of its innovative technologies. Additionally, Cue Health Inc has received recognition for its advancements in diagnostics, including winning the 2020 Fast Company's Innovation by Design Award.
Cue Health Inc is primarily present in the United States of America (USA).
Cue Health Inc represents a commitment to improving healthcare access and outcomes. The company's corporate philosophy revolves around technological innovation, convenience, and empowering individuals to take control of their health. By developing portable diagnostic devices and digital health solutions, Cue Health aims to democratize healthcare by providing accurate and timely results at the point of care. With a focus on collaborations and partnerships, Cue Health Inc strives to leverage its cutting-edge technology to revolutionize the way healthcare is delivered. This dedication to innovation and accessibility makes Cue Health Inc a leading player in the healthcare industry.
8 analist şu anda Cue Health hissesini değerlendiriyor: 0 al, 3 tut, 5 sat öneriyor. 2026 için analistler Cue Health şirketinin 213,56 M USD gelir ve -0,22 USD hisse başına kâr üretmesini bekliyor.
Güncel döviz kuruyla Cue Health hissesi 0,00 EUR (0,00 USD) seviyesindedir.
Cue Health hissesi (HLTHQ) 1 borsada işlem görür, bunlar arasında: NASDAQ (HLTH).
Cue Health Inc is a company specializing in the development of innovative medical devices and services that allow for rapid and accurate diagnosis of infectious diseases and other conditions. The company was founded in 2010 and is headquartered in San Diego, California. Cue Health has multiple business segments, including diagnostics, digital health, consumer health products, clinical trials, and distributors. These business segments offer a wide range of products and services for various markets and customers. One of Cue Health's core areas is the development and manufacturing of diagnostic devices for use in clinical practice and home use. Cue Health's flagship product is the Cue Health Monitoring Test, a handheld device that enables self-testing for a variety of health conditions, including COVID-19, influenza, and Strep-A diseases. The test can provide accurate results within minutes, speeding up decision-making for medical personnel and improving healthcare for patients. Another business segment of Cue Health is digital health. The company develops apps and platforms for remote medical monitoring and surveillance. For example, the company has developed an app that allows users to manage their health data and test results on their mobile devices. The platform also enables remote monitoring by medical professionals, which can improve patient care and treatment. Cue Health also has a consumer health product line that focuses on the needs and health issues of consumers. These products are sold in retail stores and online and include a variety of health and wellness products such as vitamins, supplements, and pain relievers. Another important business segment of Cue Health is supporting clinical trials by providing diagnostic devices and services. By collaborating with medical researchers and companies, Cue Health can play a crucial role in accelerating the development of new drugs and therapies. In addition to its business segments, Cue Health is also a major distributor of medical devices and accessories. The company works with other industry leaders to offer its customers a comprehensive range of health products and services. Overall, Cue Health has a wide range of business segments and products. The company aims to improve people's lives through better healthcare and technology. With its innovative products and services, Cue Health has taken on an important role in improving global healthcare and is expected to continue growing and expanding in the coming years.
beklenen'nin Cue Health hasılatı 213,56 M USD'dir. Bu rakam, mevcut finansal verilere dayanmakta ve şirketin iş performansını yansıtmaktadır.
beklenen'nin Cue Health karı -33,59 M USD'dir. Net kar, tüm giderleri düştükten sonra şirketin kârlılığını gösterir.
Cue Health'nin Fiyat/Kazanç (F/K) oranı şu anda -0,00'dir. F/K oranı, cari hisse fiyatını hisse başına kazançla karşılaştırır ve yatırımcıların Cue Health hisse senedinin değerlemesini değerlendirmelerine yardımcı olur.
Cue Health'nin Fiyat/Satış (F/S) oranı şu anda 0,00'dir. F/S oranı, pazar kapitalizasyonunu yıllık gelirle karşılaştırır ve Cue Health hisse senedinin değerleme metriği olarak hizmet eder.
Cue Health'nin Eulerpool Kalite Puanı 5/10'dur.
Cue Health'nin ISIN'i US2297901009'dir. ISIN (Uluslararası Menkul Kıymetler Kimlik Numarası), menkul kıymetler için küresel olarak benzersiz bir tanımlayıcıdır.
Cue Health'nin ticker'ı HLTHQ'dir. Ticker sembolü, Cue Health hisseleri borsada işlem görmek için kullanılır.
Cue Health Hissesi
Cue Health Emsaller Grubu
Cue Health Ticker
Cue Health FIGI
Cue Health'nin tüm temel göstergeleri ve derinlemesine analizi
Cue Health hissesine yönelik aktienanalizimiz, satış, kar, P/E oranı, P/S oranı, EBIT gibi önemli mali kriterleri içermekte olup, dividende bilgilerini de ele almaktadır. Ayrıca, hisseler, piyasa değeri, borçlar, özsermaye ve Cue Health şirketin yükümlülükleri gibi konuları incelemekteyiz. Bu konular hakkında daha detaylı bilgilere ihtiyacınız varsa, web sitemizin alt sayfalarında kapsamlı analizler sunuyoruz: